Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Original Article

    Protective Effect of Hesperidin on Humoral and Cell-mediated Immunity in Rat Model

    wadmin1By wadmin1April 1, 2020Updated:August 9, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Aditya Ganeshpurkar1,2,3 Ajay Saluja1,2,*
    1Faculty of Pharmacy, Gujarat Technological University, Ahmedabad, Gujarat, INDIA.
    2Shri Ram Institute of Technology- Pharmacy, Jabalpur, Madhya Pradesh, INDIA.
    3CVM’s A.R. College of Pharmacy, Vallabh Vidyanagar, Anand, Gujarat, INDIA.

    Pharmacognosy Communications,2020,10,2,83-88.
    DOI:10.5530/pc.2020.2.16
    Published: April 2020
    Type: Original Article

    ABSTRACT

    Context: Hesperidin, an important bioflavonoid, is abundantly found in various foodstuffs and can be regarded as an essential nutraceutical. Hesperidin has been acknowledged for its protective and beneficial effects on various aspects of biological system. Objectives: The present study was aimed to examine the effect of hesperidin on the regulation of the immune response in experimental animal models. Materials and Methods: The immunomodulatory effects of hesperidin were determined in rats using different experimental models including carbon clearance test, cyclophosphamide-induced neutropenia, neutrophil adhesion test, effect on serum immunoglobulin, neutrophil adhesion and indirect hemagglutination test. Hesperidin was administered orally at doses of 25, 50 and 100 mg/ kg p.o. Cyclophosphamide (30 mg/kg p.o.) was used as a standard immunosuppressant. Results: Hesperidin in all test doses demonstrated notable immunomodulatory responses in a sheep red blood cell challenge model. There was a refurbishment in the functioning of leucocytes in cyclophosphamide- treated rats and an increased clearance of carbon particles. The antibodytiter in the hemagglutination test showed increased levels of immunoglobulin. Discussion and Conclusion: The results of the present study indicate that hesperidin possesses sufficient potential for modulating immune activity by cellular and humoral mediated mechanisms.

    Key words: Hesperidin, Immunity, Antibody, Myelosuppression, Immunoglobulin.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up